SCI Abstract

search
+
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study
Muscle and skin involvement are well defined in dermatomyositis but other symptoms contribute significantly to the disease...
Patient Profile and Outcomes Among Patients with Rheumatoid Arthritis Treated with Baricitinib Versus Other Therapies in Spain: The RA-BE-REAL Study
Patient Profile and Outcomes Among Patients with Rheumatoid Arthritis Treated with Baricitinib Versus Other Therapies in Spain: The RA-BE-REAL Study
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation and pain. Baricitinib, a ta...
Saudi Clinical Practice Guidelines for Management of Axial Spondyloarthritis Disease
Saudi Clinical Practice Guidelines for Management of Axial Spondyloarthritis Disease
This guideline offers evidence-based recommendations for physicians and policymakers on managing axial spondyloarthritis (...
A Real-World Comparison of Clinical Effectiveness of Upadacitinib, Tumor Necrosis Factor Inhibitors or Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis After Switching from an Initial Tumor Necrosis Factor Inhibitor Treatment
A Real-World Comparison of Clinical Effectiveness of Upadacitinib, Tumor Necrosis Factor Inhibitors or Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis After Switching from an Initial Tumor Necrosis Factor Inhibitor Treatment
Tumor necrosis factor inhibitors (TNFi) may have insufficient efficacy in 40% of patients with axial spondyloarthritis (ax...
Risk of Major Adverse Cardiovascular Events and Thromboembolism Events in Patients with Psoriatic Arthritis on JAK Inhibitors: A Network Meta-Analysis
Risk of Major Adverse Cardiovascular Events and Thromboembolism Events in Patients with Psoriatic Arthritis on JAK Inhibitors: A Network Meta-Analysis
Our objective was to evaluate the comparative effects of five Janus kinase inhibitors (JAKis) with ten interventions, comp...
Treatment Strategies for Acute Exacerbation of Interstitial Lung Disease Associated with Systemic Autoimmune Rheumatic Diseases in Chinese Patients: A Scoping Review
Treatment Strategies for Acute Exacerbation of Interstitial Lung Disease Associated with Systemic Autoimmune Rheumatic Diseases in Chinese Patients: A Scoping Review
Connective tissue disease-related interstitial lung disease (CTD-ILD) refers to a range of pulmonary complications arising...
Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study
Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study
The aim of this study was to evaluate guselkumab efficacy through week 100 in participants with psoriatic arthrit...
The Impact of Sex on the Pattern and Clinical Response of Early Psoriatic Arthritis: Real-life Data from the Italian Prospective SIRENA Study
The Impact of Sex on the Pattern and Clinical Response of Early Psoriatic Arthritis: Real-life Data from the Italian Prospective SIRENA Study
Limited data are available on sex differences in the disease characteristics, burden and treatment outcomes of early psori...
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology–Rheumatology Clinic: A 24-Week Multicenter Study
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology–Rheumatology Clinic: A 24-Week Multicenter Study
Bimekizumab (BKZ), a monoclonal antibody targeting interleukin (IL)-17A and IL-17F, has shown high efficacy in clinical tr...
Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial
Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial
Firsekibart, an anti-interleukin (IL)-1β monoclonal antibody, has demonstrated more sustained control of gout flares ...
Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data
Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data
The journey to axial spondyloarthritis (axSpA) diagnosis is often prolonged, and delayed diagnosis has been associated wit...
Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Correction: Rheumatol Ther (2025) 12:173–202 https://doi.org/10.1007/s40744-024-00736...
Safety of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis: Results from a Real-World Canadian Setting
Safety of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis: Results from a Real-World Canadian Setting
This work aims to describe the risk of major adverse cardiovascular events (MACE), malignancy, and mortality in real-world...
The Impact of Uncontrolled Gout on Healthcare Utilization and Health Outcomes for United States Veterans Affairs Patients
The Impact of Uncontrolled Gout on Healthcare Utilization and Health Outcomes for United States Veterans Affairs Patients
Gout is an inflammatory arthritis that, when uncontrolled, can lead to chronic pain, disability, increased demand for heal...
Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren’s Disease and Association with Patient-Reported Outcomes
Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren’s Disease and Association with Patient-Reported Outcomes
Sjögren’s disease (SjD) is often characterized by the presence of anti-SSA/Ro and anti-SSB/La autoantibodies. T...
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials
The ongoing KEEPsAKE 1 and 2 (KS1; KS2) trials evaluate the efficacy and safety of risankizumab in patients with psoriatic...
Infection associated Vasculitides
Primary Systemic Vasculitides (PSV) are autoimmune idiopathic diseases. However, various infections can lead to a clinical...
Novel therapies in Sjögren’s disease: A systematic review of the literature
Available online 7 July 2025, 102084Author links open overlay panel, , , AbstractSjögren's disease (SjD) is a chronic syst...
Novel therapies – IMID Co-morbidities
Available online 12 August 2025, 102089Author links open overlay panel, , AbstractCardiovascular diseases (CVD) and metabo...
Imaging rheumatology: Emerging tools and expanding applications
Volume 39, Issue 3, September 2025, 102088Author links open overlay panel, Section snippetsCRediT authorship contribution ...
Clinical utility of ultrasound and MRI in rheumatoid arthritis: An expert review
Advanced imaging techniques are increasingly important in the diagnosis and management of rheumatoid arthritis (RA). Muscu...
Imaging in the diagnosis and management of peripheral psoriatic arthritis: Update and recent advances
Phenotypic heterogeneity and the paucity of validated biomarkers in psoriatic disease (PsD) pose clinical assessment and m...
Update of imaging in the assessment of axial spondyloarthritis
Volume 39, Issue 3, September 2025, 102064Author links open overlay panel, , , , AbstractThis update addresses new develop...
Imaging of crystal-induced arthropathies in 2025
In recent years, imaging has become an essential tool in the assessment of crystal-induced arthropathies (CIAs), including...
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by diverse manifestations, with musculoskeletal ...
New developments in ultrasound and MRI imaging of pediatric rheumatic diseases
Cookies are used by this site. Cookie SettingsAll content on this site: Copyright © 2025 Elsevier B.V., its licensors, an...
Advances in imaging techniques for Sjogren's disease
Develop and validate a composite imaging score that integrates B-mode ultrasonography, Doppler, elastography, contrast-enh...
Imaging in sarcoid disease
Volume 39, Issue 3, September 2025, 102054Author links open overlay panel, , , , , AbstractSarcoidosis is a complex multis...
Interstitial lung disease imaging for autoimmune diseases
Diffuse lung disease in patients with autoimmune disease is complex and requires accurate characterization during clinical...
Update in imaging for large vessel vasculitis
Volume 39, Issue 3, September 2025, 102060Author links open overlay panel, , AbstractDiagnostic imaging is recommended to ...
Load More
format_indent_increase